GMED
Undervalued by 51% based on the discounted cash flow analysis.
Market cap | $6.82 Billion |
---|---|
Enterprise Value | $6.72 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $1.07 |
Beta | 0.0 |
Outstanding Shares | 135,372,391 |
Avg 30 Day Volume | 929,391 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 55.49 |
---|---|
PEG | -79.31 |
Price to Sales | 4.6 |
Price to Book Ratio | 1.74 |
Enterprise Value to Revenue | 4.28 |
Enterprise Value to EBIT | 33.28 |
Enterprise Value to Net Income | 54 |
Total Debt to Enterprise | 0.06 |
Debt to Equity | 0.1 |
No data
No data